Director, Regulatory Affairs CMC jobs in United States
cer-icon
Apply on Employer Site
company-logo

Generate:Biomedicines · 5 days ago

Director, Regulatory Affairs CMC

Generate:Biomedicines is a therapeutics company pioneering Generative Biology™ to create breakthrough medicines. The Director, Regulatory Affairs will lead global regulatory strategy and execution across CMC and clinical development programs, ensuring compliance and timely submissions for biologic therapeutics.

Artificial Intelligence (AI)BiotechnologyHealth CareMedicalProduct Research

Responsibilities

Provide strategic Regulatory CMC leadership across Generate’s biologics portfolio, ensuring cohesive, phase-appropriate global strategies that support late-stage (Phase 3) development, registration, and lifecycle management
Lead the planning, preparation, and execution of global CMC regulatory submissions—including INDs, CTAs, BLAs, and MAAs—delivering timely, high-quality, and compliant documentation that meets global standards
Serve as the primary company representative for CMC-focused Health Authority interactions, leading strategy development, preparation of briefing materials, and direct engagement with agencies to clearly communicate company positions and achieve successful outcomes
Support global Phase 3 programs and registration activities by coordinating regional submissions, managing clinical and CMC amendments, and ensuring timely, high-quality responses to Health Authority queries
Partner closely with Technical Operations, Quality, and Supply Chain to integrate regulatory expectations into process development, analytical methods, quality systems, and supply-chain strategies across all stages of product development
Identify and communicate CMC-related regulatory risks and lead the development of proactive mitigation strategies in partnership with cross-functional stakeholders
Oversee submission readiness and post-submission activities, including management of regulatory commitments, agency correspondence, and follow-up actions
Stay current with evolving global CMC regulations and guidances, translating new requirements into practical internal strategies to maintain compliance and accelerate development
Provide regulatory input into clinical development plans, protocols, and study reports, ensuring strong integration between CMC, clinical, and nonclinical components to enable efficient global Phase 3 execution
Ensure compliance with internal SOPs and document-management procedures, and promote regulatory excellence by identifying opportunities to enhance documentation quality, submission efficiency, and cross-functional collaboration

Qualification

Regulatory CMC expertiseGlobal regulatory strategyHealth Authority interactionsBiologics manufacturing knowledgeECTD submission standardsRegulatory information systemsCommunication skillsLeadership skillsCross-functional collaborationProblem-solving skills

Required

10+ years of Regulatory Affairs experience in biotechnology or pharmaceutical industries, with significant expertise in Regulatory CMC and a solid understanding of clinical and nonclinical development
Proven experience supporting Phase 3 global development programs and registration submissions (IND, CTA, BLA, MAA) across multiple regions
Demonstrated success in leading CMC-related Health Authority meetings and interactions, including briefing package preparation, query management, and regulatory negotiations
Deep understanding of biologics manufacturing, analytical development, and quality systems within a regulatory framework
Strong knowledge of global regulatory requirements (FDA, EMA, MHRA, PMDA, and ICH) and experience applying them pragmatically to development programs
Familiarity with eCTD submission standards and regulatory information management systems (e.g., Veeva)
Excellent communication and leadership skills, with the ability to influence and drive decision-making in a cross-functional, matrixed environment
Bachelor's degree in a scientific discipline required

Preferred

Experience working in a fast-paced, innovative organization with complex biologics or novel modalities preferred
Advanced degree (MS, PhD, or PharmD) preferred

Benefits

Annual bonus
Equity compensation
Competitive benefits package

Company

Generate:Biomedicines

twittertwittertwitter
company-logo
Pioneering generative biology to create breakthrough therapeutics.

Funding

Current Stage
Growth Stage
Total Funding
$693M
Key Investors
Samsung Life Science FundAlumni VenturesFlagship Pioneering
2024-12-18Series Unknown
2023-09-14Series C· $273M
2021-11-18Series B· $370M

Leadership Team

leader-logo
Gevorg Grigoryan
Founding CTO
linkedin
Company data provided by crunchbase